Immunohistochemistry
Research News and Information

Saturday, November 21, 2009

Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.

29 Nov 2009 BACKGROUND: Hepatoblastoma is a rare malignancy of childhood. The scarcity of adequate cell models has limited our understanding of this tumor. Here we describe and characterize a new human liver tumor cell line, Hep293TT, derived from an aggressive ... Read more...

VEGF expression as a prognostic marker in osteosarcoma.

29 Nov 2009 BACKGROUND: The vascular endothelial growth factor (VEGF) pathway is the key regulator of angiogenesis. In osteosarcoma baseline VEGF is of proven prognostic value but prognostic potential of post-NACT VEGF expression is largely unexplored. ... Read more...

Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats.

25 Nov 2009 BACKGROUND/AIM: In cirrhosis, systemic nitric oxide (NO) overproduction and hepatic NO hypoproduction lead to arterial vasodilatation and portal hypertension. The mechanisms involved in these alterations in endothelial NO synthase (eNOS)-derived NO ... Read more...

Latest indexed articles for 'Immunohistochemistry'

These are the very latest articles for this heading:

• Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. 29 Nov 2009
• VEGF expression as a prognostic marker in osteosarcoma. 29 Nov 2009
• Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats. 25 Nov 2009
• Diagnostic value of CD163 in cutaneous spindle cell lesions. 22 Nov 2009
• Biologically active sequences in the mouse laminin alpha3 chain G domain. 8 Nov 2009
• Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies. Nov 2009
• Benign fibroblastic polyps of the colon. 30 Oct 2009
• Decreased brain edema after collagenase-induced intracerebral hemorrhage in mice lacking the inducible nitric oxide synthase gene. Laboratory investigation. 30 Oct 2009
• p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma. 30 Oct 2009
• T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity. 30 Oct 2009
• Lymphocyte-depleted thymic remnants: a potential diagnostic pitfall in the evaluation of central neck dissections. 30 Oct 2009
• Immunophenotypic variations in mantle cell lymphoma. 30 Oct 2009
• Lipid raft-targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively. 30 Oct 2009
• Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold. 30 Oct 2009
• C-terminal region-dependent change of antibody-binding to the Eighth Reelin repeat reflects the signaling activity of Reelin. 30 Oct 2009
• Localization of zip1 and zip4 mRNA in the adult rat brain. 30 Oct 2009
• The small heat shock protein Hsp27 protects cortical neurons against the toxic effects of beta-amyloid peptide. 30 Oct 2009
• Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth. 30 Oct 2009
• Adult cerebrospinal fluid inhibits neurogenesis but facilitates gliogenesis from fetal rat neural stem cells. 30 Oct 2009
• Identification of alternate transcripts of neuronal nitric oxide synthase in the mouse retina. 30 Oct 2009

See a longer list of these articles.

Technical information about 'Immunohistochemistry'

Definition: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.

Descriptor UI: D007150

Alternative terms: Immunohistochemistry; Immunolabeling Techniques; Immunolabeling Technique; Technique, Immunolabeling; Techniques, Immunolabeling; Immunolabeling Technics; Immunolabeling Technic; Technic, Immunolabeling; Technics, Immunolabeling; Immunogold Techniques; Immunogold Technique; Technique, Immunogold; Techniques, Immunogold; Immunogold Technics; Immunogold Technic; Technic, Immunogold; Technics, Immunogold; Immunohistocytochemistry; Immunogold-Silver Techniques; Immunogold Silver Techniques; Immunogold-Silver Technique; Technique, Immunogold-Silver; Techniques, Immunogold-Silver; Immunogold-Silver Technics; Immunogold Silver Technics; Immunogold-Silver Technic; Technic, Immunogold-Silver; Technics, Immunogold-Silver; Immunocytochemistry;

Allowable Qualifiers: history; instrumentation; methods; standards; trends; utilization; veterinary; statistics & numerical data; ethics; classification; economics;

Tree Number: E01.450.495.435; E05.200.500.607.512; E05.200.750.551.512; E05.478.594.430; H01.158.100.656.234.512; H01.158.201.344.512; H01.158.201.486.512; H01.181.122.573.512; H01.181.122.605.512;

History Note: 88

Technical Notes: GEN; avoid as coord; SPEC qualif when IM; no qualif when NIM; immunohistochem of disease is disease /diag or /metab